Identification of non-peptide malignant brain tumor (MBT) repeat antagonists by virtual screening of commercially available compounds.
about
Structure-based virtual screening for drug discovery: a problem-centric reviewSmall-Molecule Ligands of Methyl-Lysine Binding ProteinsReaders of histone methylarginine marks.Methods for Activity Analysis of the Proteins that Regulate Histone MethylationWriting and rewriting the epigenetic code of cancer cells: from engineered proteins to small moleculesBiophysical probes reveal a "compromise" nature of the methyl-lysine binding pocket in L3MBTL1.High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.Towards understanding methyllysine readout.Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1.Assessment of free energy predictors for ligand binding to a methyllysine histone code reader.Identification and Structure-Activity Relationship Studies of Small-Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1.Developing Spindlin1 small-molecule inhibitors by using protein microarrays.Progress in the discovery of small-molecule inhibitors of bromodomain--histone interactions.Drug discovery toward antagonists of methyl-lysine binding proteinsMind the methyl: methyllysine binding proteins in epigenetic regulation.A Structural Perspective on Readout of Epigenetic Histone and DNA Methylation Marks.Tuning HP1α chromodomain selectivity for di- and trimethyllysine.
P2860
Q27022502-6517AB58-94D4-4F34-82B5-15F66E30183CQ27667285-6B19AFE1-A02E-434C-9276-A906BDE94E59Q30359633-280C0F0E-D9DA-458D-99BD-946BA6998998Q34037729-E5ACA0C4-9DA3-4BF5-B6FE-D8FDEF442379Q34476349-A42CD02A-8407-4BCD-AD5C-5E1163BFEC7CQ34859321-18586D30-D2EB-4A93-BD6C-81E0E360D054Q35131115-52FEF784-4B14-4F24-A9A1-A6B8A920B462Q35146397-D2920E5F-CF6C-4E44-8B5A-02A1C4BFD051Q35472154-832BBC29-48F6-41DB-BFCF-344A9B80C43CQ35748444-F9870483-0E66-49F9-8B9C-5D48E95CCB55Q36135192-AC0B41DA-E74D-46F7-99FA-F102596DA101Q36371775-788C52A8-887E-412F-8C43-7437609F0BF1Q37940197-0ADCB934-4282-4BB1-AD46-F3A1F9D0DC2CQ37965165-814D7A02-4520-4090-B591-21C3EBB21C29Q38180674-233372B6-7485-4EE6-8251-18F083FFBE89Q38756663-6EBB16DF-0DCD-4A69-AD5A-EEBCF69F89ABQ52730179-EEA31BDD-C894-4940-9ED8-E39E61D87752
P2860
Identification of non-peptide malignant brain tumor (MBT) repeat antagonists by virtual screening of commercially available compounds.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of non-peptide ...... mercially available compounds.
@ast
Identification of non-peptide ...... mercially available compounds.
@en
type
label
Identification of non-peptide ...... mercially available compounds.
@ast
Identification of non-peptide ...... mercially available compounds.
@en
prefLabel
Identification of non-peptide ...... mercially available compounds.
@ast
Identification of non-peptide ...... mercially available compounds.
@en
P2093
P2860
P356
P1476
Identification of non-peptide ...... mercially available compounds.
@en
P2093
Dmitri Kireev
J Martin Herold
Jacqueline Norris-Drouin
Stephen V Frye
Tim J Wigle
William P Janzen
P2860
P304
P356
10.1021/JM1007374
P407
P577
2010-11-01T00:00:00Z